This Report provided by 24 Market Reports is about, Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period" discusses the drug delivery technologies and trends in the market and the evolving business strategies being adopted and leveraged by companies globally. The ultimate goal of drug delivery research is to develop formulations and devices that can be used in clinical applications to treat various diseases.
Injectable Drug Delivery Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Drug Delivery Technology market will be able to gain the upper hand as they use the report as a powerful resource.
The Asia Pacific Connected Injectable Drug Delivery Devices market size is $XX million USD in 2018 with XX CAGR from 2015 to 2018, and it is expected to reach $XX million USD by the end of 2025 with a CAGR of XX% from 2020 to 2025.
The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations.
This Future Market Insights (FMI) report examines the global injectable drug delivery market for the period 2018–2028. The primary objective of the report is to offer insights into market opportunity for the injectable drug delivery market.
Europe Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Usage Pattern (Curative Care, Immunization, Other), Mode Of Administration (Skin, Circulatory/Muskoskeletal, Organs, Central Nervous System), Application (Autoimmune Disease, Hormonal Disorders, Orphan Diseases, Oncology, Others), End User (Hospitals and Clinics, Home Healthcare, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy)
According to the latest research report by IMARC Group, The global needle-free drug delivery technology market size reached US$ 4.18 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.72 Billion by 2028, exhibiting a growth rate (CAGR) of 5.22% during 2023-2028. More Info:- https://www.imarcgroup.com/needle-free-drug-delivery-technology-market
The market for injectable drug delivery is estimated to increase rapidly over the forecast period. Sedentary lifestyles have spread over the world as a result of rapid technological adoption. Obesity rates are rising as a result of this shift in lifestyle, which is leading to a slew of chronic ailments including diabetes and cardiovascular disease.
Drug delivery generally refers to formulations, approaches, technologies and systems for transporting a pharmaceutical compound in the body. The injectable drug delivery devices consist of needle-free injectors, conventional syringes, auto injectors and pen injectors.
The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to latest analysis by Emergen Research. Injectable drug delivery market revenue growth is owing to a rising trend of pre-filled syringes along with technological developments.
The injectable drug delivery market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,293.29 million by 2028 and will grow at a CAGR of 12.9% in the above mentioned forecast period.
Drug delivery technology market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 7.65% in the above-mentioned forecast period. https://www.databridgemarketresearch.com/reports/global-drug-delivery-technology-market
The global injectable drug delivery market was valued at US$ 30.5 Bn in 2018, and is expected to exhibit a CAGR of around 9% during the forecast period (2019–2029).
Drug delivery generally refers to formulations, approaches, technologies and systems for transporting a pharmaceutical compound in the body. The injectable drug delivery devices consist of needle-free injectors, conventional syringes, auto injectors and pen injectors.
The growing number of elderly persons is a large consumer of home care drug delivery devices. Expanding applications of drug delivery into niche therapeutic areas, strategic collaborations and self-administration and home care drug delivery devices represent vast opportunities for key players in this market.
The growing cases and prevalence of chronic diseases globally is likely to accelerate the growth of drug delivery technology market in the forecast period of 2020-2027. On the other hand, launch of advanced new products and advancement in technologies will further boost various opportunities in the growth of the drug delivery technology market in the above mentioned forecast period.
With the increasing number of epileptic seizures due to greater exposure to perinatal risk factors and higher rates of CNS disease, the injectable seizure market is the leading choice of dosage form for seizure treatment.
European Drug Delivery Technologies and Nasal sprays Market report categorizes the European Market by Technologies (Auto Injectors, Transdermal Patches , Injectable, Ocular, Transdermal , Oral, Pulmonary, Nasal, Topical, Implantable, and Transmucosal Drug Delivery) & by Geography.
For more information kindly visit : https://www.bharatbook.com/medical-devices-market-research-reports-732747/drug-delivery-technology-route-administration-end-user-forecast.html Bharat Book Bureau provides the report, on “ Market Research Report on Drug Delivery Technology [2020] ”.The drug delivery technology market is expected to reach USD 1,504.7 billion by 2020 from USD 1,048.1 billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. The market is categorized on the basis of route of administration, end user, and region.
The European injectable drug delivery technologies market was valued at $6.8 billion in 2012; it is expected to reach $12.4 billion by 2017 at a CAGR of 12.7% from 2012 to 2017.
The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020.
The Global Injectable Drug Delivery Market accounted for $26.8 billion in 2014 and is expected tgrow at a CAGR of 13.9% treach $76.1 billion by 2022. The factors driving the injectable drug delivery market include rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices. Chronic disease rates are increasing at 14% each year. In 2012, 63% of the deaths across the world were due tchronic diseases.
The growing cases and prevalence of chronic diseases globally is likely to accelerate the growth of drug delivery technology market in the forecast period of 2020-2027. On the other hand, launch of advanced new products and advancement in technologies will further boost various opportunities in the growth of the drug delivery technology market in the above mentioned forecast period.
The North American drug delivery technologies market is projected to reach USD 758.7 Billion by 2021 from USD 520.0 Billion in 2016, at a CAGR of 6.5%.
Drug delivery technology market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 8326.45 billion by 2027 growing at a CAGR of 7.65% in the above-mentioned forecast period. The increasing demand for effective delivery technique of biopharmaceuticals and the improvement in the ability and safety of drug by controlling the drug release in the body are the factors influencing the growth in the market.
The North American market was valued at $66.7 billion in 2012 and is poised to reach $102.2 billion by 2017. The U.S. registered a higher market share, valued at $59.3 billion in 2012 and is expected to grow at a high single digit CAGR from 2012 to 2017.
Top 10 Drug Delivery Technologies Market research report intensively evaluates drug delivery technologies with respect to revenues, growth, therapeutic areas, patents registered and industry focus to arrive at top 10 drug delivery technologies.
Various bacteria and microorganisms can enter the body to for a new infection via various mucosal sites. There is a huge amount of vaccines licensed at the moment that are parenterally administered. They can build strong immunity but cannot generate mucosal immunity. Nasal vaccinations are used on a large scale for the foundation of immunity for infections, which specifically enter through the mucus. Administration through mucosal sites, especially through nasal route, adds up to the promising and alternative measures for the delivery of vaccines and drugs.
Various bacteria and microorganisms can enter the body to for a new infection via various mucosal sites. There is a huge amount of vaccines licensed at the moment that are parenterally administered. They can build strong immunity but cannot generate mucosal immunity. Nasal vaccinations are used on a large scale for the foundation of immunity for infections, which specifically enter through the mucus. Administration through mucosal sites, especially through nasal route, adds up to the promising and alternative measures for the delivery of vaccines and drugs.
Injectable suspensions play a vital role in modern healthcare, providing sustained release formulations of medications for various therapeutic purposes. The global market for injectable suspensions demonstrates robust growth, fueled by increasing prevalence of chronic diseases, advancements in drug delivery technologies, and growing demand for long-acting injectable formulations. According to the latest research by Persistence Market Research, the injectable suspensions market is set to witness positive growth of CAGR 8.7% during 2021-2031.
The global Liposome Drug Delivery Market size is projected to reach a CAGR of 9.8% from 2023-2030. Liposome drug delivery is a way of administering a medication that increases its bioavailability and reduces toxicity. Liposomes are tiny vesicles made from naturally occurring molecules in the body, which can transport drugs into targeted cells for improved effectiveness while reducing side effects compared to conventional methods like intravenous injections or oral medications. The Liposome-mediated drug delivery technology is one of the most promising approaches to treating cancers and other diseases.
The subcutaneous drug delivery devices market was valued at US$ 9,243.80 million in 2018 and it is projected to reach US$ 17,290.47 million in 2027; it is expected to grow at a CAGR of 7.4% from 2019 to 2027.
The Advanced Parenteral Drug Delivery Devices Market size is forecasted to reach $18.4 billion by 2027 and is expected to grow at a CAGR of 8.6% during the forecast period 2022-2027.
The global drug delivery systems market is estimated to garner a modest revenue of by the end of 2033 by growing at a CAGR of ~10% over the forecast period, i.e., 2023 – 2033
The Business Research Company offers electronic drug delivery systems market research report 2023 with industry size, share, segments and market growth
Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.
The global on body drug delivery systems market is expected to register a revenue CAGR of 6.0% during the forecast period. Increasing prevalence of chronic diseases and cancer, rising technological advancement in on body drug delivery systems, increasing product launching and investments by leading companies are some of the key factors driving revenue growth of the on body drug delivery systems market. In addition, rising demand for self-administrative injections is contributing significantly to revenue growth of the market.
The drug delivery system market was valued at US$ 1,243,111.7 million in 2018 and it is projected to reach US$ 2,302,227.2 million in 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027.
Pulmonary Drug Delivery Market & Clinical Pipeline Insight @ http://www.reportsnreports.com/reports/285693-pulmonary-drug-delivery-market-clinical-pipeline-insight.html The pulmonary technology offers an exclusive and inventive alternative for drug delivery as it allows for a systemic delivery of large and small molecule drugs through inhalation into the lungs. This mode of drug delivery have helped in reducing the adverse effects of low solubility and absorption of drugs which are present in the other therapies through the oral, intravenous and injection routes.
Injectable seizure drugs are important in treating emergencies of clinical seizure emergencies and in other treatments where oral administration is not possible.
The drug delivery system market was valued at US$ 1,243,111.7 million in 2018 and it is projected to reach US$ 2,302,227.2 million in 2027; it is expected to grow at a CAGR of 7.2% from 2019 to 2027
Persistence Market Research has delivered key insights and presented a revised forecast of the global sterile injectable drugs market for a period of 8 years from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based factors driving the demand, as well as the recent developments of key market participants.
Industry Report “Needle-Free Drug Delivery Devices Market Research Report – Forecast to 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement
The global advanced dermatology drug delivery devices market size is expected to grow from USD 3,569.8 million in 2021 to USD 8,783.0 million by 2030, at a CAGR of 10.5% from 2022 to 2030. The global advanced dermatology drug delivery devices market is driven by factors such as the global efforts in increasing the adoption of connected devices, increasing number of business synergies with pharmaceutical companies, novel technologies in drug delivery, and the growing focus on prescription/medication adherence. Manufacturers are more focused on producing devices that offer enhanced patient experience through real-time monitoring and data sharing.